scholarly article | Q13442814 |
P2093 | author name string | A M James Shapiro | |
P2860 | cites work | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice | Q33803861 | ||
A new method for incorporating functional heparin onto the surface of islets of Langerhans | Q34238228 | ||
Islet transplantation for brittle type 1 diabetes: the UIC protocol | Q34774804 | ||
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade | Q34976218 | ||
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes | Q40381268 | ||
Insulin independence after living-donor distal pancreatectomy and islet allotransplantation | Q40423359 | ||
Recovery from diabetes in mice by beta cell regeneration | Q42408079 | ||
Automated method for isolation of human pancreatic islets | Q42516583 | ||
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success | Q43153441 | ||
Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction | Q43225003 | ||
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture | Q43263229 | ||
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. | Q43669824 | ||
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes | Q45267369 | ||
Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. | Q46170683 | ||
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice | Q46345366 | ||
Low molecular weight dextran sulfate is well tolerated in humans and increases endogenous expression of islet protective hepatocyte growth factor | Q47203503 | ||
High-density culture of human islets on top of silicone rubber membranes | Q47688191 | ||
Effect of tumor necrosis factor alpha and of the soluble tumor necrosis factor receptor on insulin secretion of isolated islets of Langerhans | Q67867806 | ||
Unraveling the secrets of single donor success in islet transplantation | Q76316313 | ||
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes | Q79552575 | ||
Repurification: rescue rather than routine remedy | Q81239019 | ||
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation | Q81790383 | ||
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? | Q82272024 | ||
Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α | Q83591286 | ||
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice | Q84149425 | ||
Anti-inflammatory properties of exenatide in human pancreatic islets | Q84349939 | ||
P433 | issue | 6 | |
P304 | page(s) | 627-631 | |
P577 | publication date | 2011-12-01 | |
P1433 | published in | Current opinion in organ transplantation | Q26842426 |
P1476 | title | Strategies toward single-donor islets of Langerhans transplantation | |
P478 | volume | 16 |
Q39346862 | A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation |
Q38126385 | Anti-inflammatory strategies to enhance islet engraftment and survival |
Q35151554 | Beneficial effect of insulin treatment on islet transplantation outcomes in Akita mice. |
Q90646990 | Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas |
Q38126884 | Biologic agents in islet transplantation |
Q87039180 | Current status of clinical islet transplantation |
Q38103329 | Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: a systematic review. |
Q34132207 | Ex vivo Expansion of Human Adult Pancreatic Cells with Properties of Distributed Stem Cells by Suppression of Asymmetric Cell Kinetics |
Q41817143 | Filtration is a time-efficient option to Histopaque, providing good-quality islets in mouse islet isolation |
Q27002000 | Human pancreatic islet transplantation: an update and description of the establishment of a pancreatic islet isolation laboratory |
Q42152837 | Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo |
Q50856415 | Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation. |
Q35882545 | Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist |
Q35227182 | Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes |
Q27010290 | Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges |
Q37098988 | Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation |
Q36030491 | Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation |
Q34603880 | Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice. |
Q38210810 | Minimizing immunosuppression in islet xenotransplantation. |
Q47787665 | Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. |
Q40597576 | National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities |
Q55411971 | New Automatized Method of 3D Multiculture Viability Analysis Based on Confocal Imagery: Application to Islets and Mesenchymal Stem Cells Co-Encapsulation. |
Q47862186 | Novel Fusion Protein Targeting Mitochondrial DNA Improves Pancreatic Islet Functional Potency and Islet Transplantation Outcomes |
Q52684486 | Oxygen-permeable microwell device maintains islet mass and integrity during shipping. |
Q38218567 | Pancreatic islet transplantation: from dogs to humans and back again |
Q36523515 | Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site. |
Q35322638 | Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets |
Q34079626 | Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review |
Q42565984 | Temperature profiles of different cooling methods in porcine pancreas procurement. |
Q36263810 | The Spleen Is an Ideal Site for Inducing Transplanted Islet Graft Expansion in Mice |
Q37340689 | Transplantation of human islets without immunosuppression |
Q39899937 | Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. |